Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis

9d ago

ENLV

PremiumPress Releases

Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis

13d ago

ENLV

PremiumCompany Announcements

Enlivex’s Allocetra™ Shows Promise in Sepsis Trial

14d ago

ENLV

PremiumPress Releases

Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis

14d ago

ENLV

PremiumCompany Announcements

Enlivex Therapeutics’ Stable Financial Outlook

26d ago

ENLV

More ENLV News >

ENLV News on the Web

2024-04-22

Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis

Yahoo Finance

Neutral

2024-04-16

Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis

Yahoo Finance

Neutral

2024-04-15

Enlivex Stock Plummets 51% in a Week: Here's Why

Yahoo Finance

Neutral

2024-04-15

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Zacks

Bullish

2024-04-11

Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis

Yahoo Finance

Neutral

2024-04-11

Enlivex’s Allocetra™ Shows Promise in Sepsis Trial

TipRanks News

Neutral

2024-04-11

Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis

Yahoo Finance

Neutral

2024-04-05

ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023

InvestorPlace

Neutral

News Score - Last 7 Days

Neutral

ENLV

Sector Average

Media Buzz

This Week1 articles

Weekly Average2.25 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ENLV’s Media Buzz Sentiment?

1 articles about ENLV were published this week. In an average week, 2.25 articles are published.

What is ENLV’s weekly average amount of articles?

In an average week, 2.25 articles about ENLV are published.

What is ENLV’s News Sentiment?

50% of articles about ENLV were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

NBIXNeurocrine

AMEDAmedisys

HSTMHealthStream

IMVTImmunovant

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing